This website has been produced and funded by Novo Nordisk and is intended for adolescent
patients aged 12–17 years in United Kingdom who have been prescribed Wegovy®▼ (semaglutide injection)
and their carers. Side effect reporting information can be found in the footer of this page.
Welcome to the Wegovy®▼ (semaglutide injection) website for adolescent patients and their carers
Patient Resources
This website has been produced and funded by Novo Nordisk UK to provide information about Wegovy® for weight management. The website is designed to provide a range of resources to support adolescent patients aged 12–17 years who have started on Wegovy® for weight management.
This information does not replace the Patient Information Leaflet (PIL), which patients and their carers are advised to read in full. It is not intended as a substitute for clinical advice provided by a healthcare professional. Please contact a healthcare professional if you have any questions about this treatment and for clinical advice.
In the list below, you can access the links to the Wegovy® Patient Information Leaflet, which can be found on the electronic Medicines Compendium (eMC).
Wegovy® Patient Information Leaflet (PIL)
Wegovy® 0.25 mg, FlexTouch® solution for injection in pre-filled pen
Wegovy® 0.5 mg, FlexTouch® solution for injection in pre-filled pen
Wegovy® 1 mg, FlexTouch® solution for injection in pre-filled pen
Wegovy® 1.7 mg, FlexTouch® solution for injection in pre-filled pen
Wegovy® 2.4 mg, FlexTouch® solution for injection in pre-filled pen
A guide to supporting you with your Wegovy®
treatment
We have developed a digital booklet with you in mind to support you throughout your Wegovy® treatment. It will give you information about Wegovy®, how Wegovy® works, how to take it and some lifestyle advice that may help you on your Wegovy® journey.
If you have any questions or queries, please speak with your healthcare professional.
Instructions on how to use your once-weekly Wegovy® FlexTouch® pen
Starting a medicine can be nerve-racking, and it's normal to feel worried about injecting your first dose. We have created a video to help you learn how to use the once-weekly Wegovy® FlexTouch® pen.
Before you begin using your once-weekly Wegovy® FlexTouch® pen, always read these instructions carefully, and talk to your doctor, nurse or pharmacist about how to inject Wegovy® correctly.
Reporting side effects
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information promptly. You can help by reporting any side effects you may get. See https://yellowcard.mhra.gov.uk/ for how to report side effects.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. Side effects should also be reported to Novo Nordisk Limited (Telephone Novo Nordisk Customer Care Centre 0800 023 2573). Calls may be monitored for training purposes. By reporting side effects, you can help provide more information on the safety of this medicine.